Search clinical trials for: BC 007

Total 2162 results

Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Suspended

SY007 in Patients With Acute Ischemic Stroke

Acute Ischemic Stroke

China
Recognify Life Sciences

Completed

Safety, Biomarker Study of RL-007 in Subjects With Schizophrenia

Schizophrenia | Cognitive Impairment

United States
Hvivo
Prep Biopharm Limited

Completed

Study Examining PrEP-001 in Healthy Subjects

Influenza A H3N2

United Kingdom
Institut Cancerologie de l'Ouest

Terminated

Quality of Life and Psychological Vulnerability in Patients With RH+ Metastatic Breast Cancer (EPOCA)

Metastatic Breast Cancer | Positive Hormonal Receptors

France
Medical University of Warsaw

Completed

Short and Long-term Results of Arterial Stiffness and Central Aortic Pressure After Kidney Transplantation (PWV/CP/KTx)

Arterial Calcification | Aortic Stiffness | High Blood Pressure (& [Essential Hypertension])

Poland
Preferred Medicine, Inc
M.D. Anderson Cancer Center

Recruiting

Droplet-BC Screening Test for the Detection of Breast Cancer, the DROPLET-BC Study

Breast Carcinoma

United States
University of South Florida

Completed

Efficacy of MBSR Treatment of Cognitive Impairment Among Breast Cancer Survivors

Breast Cancer

United States
Oblato, Inc.

Recruiting

Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients With Recurrent High-Grade Glioma

Astrocytoma | Glioblastoma Multiforme | Oligodendroglioma | High-grade Glioma

United States
University of Manchester
University of Nottingham; Queen Mary University of London; Manchester University... and other collaborators

Completed

What Are the Benefits and Harms of Risk Stratified Screening in the NHS Breast Screening Programme: Study Protocol

Breast Cancer

United Kingdom
Anchiano Therapeutics Israel Ltd.

Completed

Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer

Superficial Bladder Cancer

Israel, United States
Virchow Group
Adocia

Completed

Comparative Study of 3 Dose Regimens of BioChaperone to Becaplermin Gel for the Treatment of Diabetic Foot Ulcer

Diabetic Foot Ulcers

India
Nanjing Leads Biolabs Co.,Ltd

Recruiting

Phase Ib/II Clinical Study of LBL-007 in Treatment of Advanced Malignant Tumors

Advanced Solid Tumor

China
Mustafa Kemal University

Completed

Influence of Sonic Activation of Root Sealers on Post-Operative Pain

Apical Periodontitis | Post Operative Pain

Turkey
Universitat Internacional de Catalunya

Completed

Regenerative Combined Therapy With Enamel Matrix Derivative and Biphasic Calcium Phosphate Graft

Intrabony Periodontal Defect
Smiths Medical, ASD, Inc.

Completed

RIGHT IV Pilot Study (RIGHT IV)

Peripheral Intravenous Catheters

United States
Loughborough University
University of Bedfordshire

Completed

Is Mid-morning Breakfast as Healthy as Early-morning Breakfast for Blood Sugar Control in Adolescent Girls?

Postprandial Hyperglycemia

United Kingdom
Castle Creek Biosciences, LLC.

Active, not recruiting

A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (DEFI-RDEB)

Recessive Dystrophic Epidermolysis Bullosa

United States
Morphotek

Completed

A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers

Pancreatic Cancer | Ovarian Cancer | Mesothelioma | Non-small Cell Lung Cancer

United States
Lin BioScience, Inc
Lin BioScience Pty Ltd

Recruiting

The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias

Relapsed or Resistant Acute Leukaemias

Taiwan, Australia
Avalo Therapeutics, Inc.

Completed

Phase 1b Study of AEVI-007 in Subjects With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States
National Heart, Lung, and Blood Institute (NHLBI)
Zymedi, Co., Ltd.

Recruiting

Study of Intravenous ZMA001 in Healthy Subjects

Pulmonary Arterial Hypertension PAH

United States
Sheba Medical Center

Unknown

Evaluating the Physiological Strain Induced by a BC Membrane Protective Garment Under Exercise-heat Stress Compared to a Protective Coverall

Physiological Stress

Israel
Oblato, Inc.

Active, not recruiting

Clinical Trial of IV OKN-007 in a Pilot Cohort of Human Recurrent Malignant Glioma Patients (OKN-007)

Recurrent Malignant Glioma

United States
Intra-Cellular Therapies, Inc.

Completed

Receptor Occupancy of ITI-007 Using Positron Emission Tomography (PET) in Patients With Stable Schizophrenia

Schizophrenia

United States
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

A Controlled Clinical Study of 2 Different Moisturizers for the Relief of Dry Skin

Skin Care | Skin | Skin Cream

United States
EGEN, Inc.

Completed

Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian Cancer

Ovarian Neoplasms

United States
Miami Research Associates
Ganeden Biotech, Inc.

Completed

A Study on Intestinal Gas Symptoms to Evaluate the Effects of Gas Defense in Otherwise Healthy Adult

Abdominal Pain | Flatulence | Abdominal Cramps

United States, Dominican Republic
Oblato, Inc.

Available

Expanded Access to OKN-007 for Patients With Diffuse Midline Glioma, H3 K27-altered

Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant

United States
Applied Therapeutics, Inc.

Active, not recruiting

AT-007 in Adult Subjects With Classic Galactosemia (CG)

Classic Galactosemia

United States
Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Completed

Single-dose Incremental Intravenous Injection of SY-007 in Healthy Subjects

Cerebral Apoplexy

China
AbbVie

Terminated

A Study of SC-007 in Subjects With Advanced Cancer

Gastric Cancer | Colorectal Cancer (CRC)

United States
Tigris Pharmaceuticals

Completed

A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL) (TG-003)

Cervical Intraepithelial Neoplasia | Uterine Cervical Dysplasia

United States
DEKK-TEC, Inc.

Completed

Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders

HIV Infections | Lymphoproliferative Disorders | Sarcoma, Kaposi

United States
Recognify Life Sciences

Recruiting

A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS)

Schizophrenia | Cognitive Impairment | Cognitive Impairment Associated With Schizophrenia (CIAS)

United States
M.D. Anderson Cancer Center

Active, not recruiting

Tegavivint for the Treatment of Relapsed or Refractory Leukemia

Refractory Leukemia | Recurrent Leukemia

United States
Washington University School of Medicine
Wugen, Inc.

Recruiting

Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies

Acute Myeloid Leukemia | Sezary Syndrome | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult T Cell Leukemia | Adult T Cell Lymphoma | Hepatosplenic T-cell Lymphoma | Peripheral T Cell Lymphoma | Extranodal NK/T-cell Lymphoma | Enteropathy-Associated T-Cell Lymphoma | T-Cell Non-Hodgkin... and other conditions

United States
Intra-Cellular Therapies, Inc.

Terminated

ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease

Agitation in Dementia, Including Alzheimer's Disease

United States
Intra-Cellular Therapies, Inc.

Completed

Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia

Alzheimer's Disease

United States
Ohio State University Comprehensive Cancer Center

Recruiting

Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer

Metastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8

United States
C. R. Bard

Completed

Prospective Feasibility Trial of AccuCath 2.25" Blood Control (BC) Placed in Difficult Access Patients in the Emergency Department

Vascular Access Complication

United States
Medical University of Warsaw

Completed

Estimated Glomerular Filtration Rate After Kidney Transplantation - the Formula MDRD, CKD-EPI or Cockroft-Gault? (eGFR)

Renal Function Disorder

Poland
Inmagene LLC

Active, not recruiting

Safety and Pharmacokinetics of Subcutaneous Dose of IMG-007 in Healthy Participants

Healthy Volunteers

Australia
Erasca, Inc.

Active, not recruiting

A Study of ERAS-007 as Monotherapy or in Combination With ERAS-601 in Patients With Advanced or Metastatic Solid Tumors (HERKULES-1)

Advanced or Metastatic Solid Tumors

United States
New York State Psychiatric Institute
Intra-Cellular Therapies, Inc.

Terminated

ITI-007 (Lumateperone Tosylate) for Schizophrenia

Schizophrenia

United States
Qilu Pharmaceutical Co., Ltd.

Unknown

A Study to Investigate the Safety, Efficacy and PK of Multiple Doses of QL-007 in Chronic Hepatitis B Patients in CHINA (QL-007)

Chronic Hepatitis b

China
Duke University
National Institute of Allergy and Infectious Diseases (NIAID); Vanderbilt University

Completed

Rapid Identification and Phenotypic Susceptibility Testing for Gram-Negative Bacteremia (RAPIDS-GN)

Gram-negative Bacteremia

United States
Applied Therapeutics, Inc.

Completed

Safety and Pharmacokinetics of AT-007 in Healthy Subjects and in Adult Subjects With Classic Galactosemia

Classic Galactosemia

United States
Wugen, Inc.

Enrolling by invitation

A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007

T-cell Acute Lymphoblastic Leukemia | T-cell Lymphoblastic Lymphoma

United States, Australia
Nabriva Therapeutics AG
Quotient Clinical

Completed

A Study to Assess Mass Balance Recovery, Metabolite Profile and Identification of IV and Oral 14C-BC-3781

Healthy

United Kingdom
BioChemics, Inc.
Harrison Clinical Research

Withdrawn

Safety and Efficacy Study of BC-DN-01 in Painful Diabetic Peripheral Neuropathy

Diabetic Neuropathy, Painful

United Kingdom

Search clinical trials for: BC 007

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations